4
Changes in Ownership
ARS Pharmaceuticals, Inc. Filed Acc 0001951287-26-000004
Chief Commercial Officer sold 25,000 shares at $10.00 ($250,000)
- Chief Commercial Officer acquired 25,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Karas Eric Chief Commercial Officer | 2026-06-12 | Option exercise 10b5-1 | +25,000 | $1.50 | $37,500 | 37,176 | D |
| Karas Eric Chief Commercial Officer | 2026-06-12 | Sale 10b5-1 | −25,000 | $10.00 | $250,000 | 12,176 | D |
| Derivatives | |||||||
| Karas Eric Chief Commercial Officer | 2026-06-12 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 519,588 | D | ||
| Open-market sales · 25,000 sh · avg $10.00 · $250,000 | |||||||
Loading xslF345X06/form4-06132026_120610.xml…